The association of hyperornithinaemia (HO) and gyrate atrophy (GA) first described in 1973 (SimeU & Takki 1973 ) has now been reported in at least 30 patients (Takki & Simell 1976 , McCulloch & Marliss 1975 , Yatziv et al. 1979 . The condition is due to a deficiency of the enzyme ornithine ketoacid transaminase (OKT) which results in high levels of ornithine in the plasma, cerebrospinal fluid and aqueous humour, low plasma lysine but with normal plasma ammonia levels ( Figure I) (Shih et al. 1978) . It is transmitted by an autosomal recessive gene.
The two siblings reported here with HOGA are not only the first West Indians to be described but also the first cases to be reported in the British literature. In an attempt to decrease their plasma ornithine levels and thereby slow the progression of the gyrate atrophy they were treated with lysine hydrochloride. a low protein diet and pyridoxine. prednisolone (Rokseth 1960) and it is therefore probable that sUlphasalazin~was the ca~se. of t~e agranulocytosis and erythroid hypoplasia In this patient.
. . Toxic epidermal necrolysis has been described in association with staphylococcal infection (Lyell 1956 ). The organism is usually phage.group.II (type 71) and histology reveals superficial ep~dermal splits. In this patient, however, the epidermal changes and staphylococcal phage type suggestet hat necrolysis was not due to the staphylococci isolated. Sulphasalazine has previously been implicated as a cause of non-fatal toxic epidermal necrolysis (Strom 1969) and would appear the most likely aetiological factor in this patient. o141-<l768j80j080S88-<l4jS02.00jO
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Case reports JM, born in the West Indies in 1965, was referred in 1977 at the age of thirteen to a child psychiatrist because of withdrawn personality and short stature. She suffered severe emotional and physical deprivation until the age of ten years when she came to England. Her parents are unrelated and she has five siblings. She was a withdrawn, small child (height just below, and weight at, the third percentile) with puberty (Stage IV). Apart from myopia her eyes were found to be normal in 1977 but the first changes of GA were noted in 1978 ( Figure 2 ). The initial investigations included urine thin-layer chromatography. The amino acid pattern showed a large band in the ornithine-lysine position, some cystine and one unknown spot. A provisional diagnosis of cystinuria was made but because of the atypical nature of the unknown band urine and plasma were analysed by ionexchange chromatography. Urinary ornithine was grossly increased and the plasma ornithine level was 10 times normal; the lysine levels were low (Table 1) (Oberholzer & Briddon 1978) .
AM, aged seven years, was the only other member of the family found to have the same disorder. She was a normal child, apart from myopia found at the age of six years; changes of G A were first seen in 1978. e includes a-amino n-butyric acid JM and AM both have increased urinary clearances of lysine, arginine, cystine and serine (Table 1 ). Apart from low plasma creatinine levels, routine biochemical tests, including plasma ammonia determined pre-and post-prandially, were normal for both AM and JM. Audiograms, IQ, and EEG (JM only) were also normal.
Ornithine loading tests (Takki & Simell 1976) were performed on the family (father unavailable). The rate of ornithine metabolism as judged by the fall in plasma ornithine level over a 2-hour period was significantly lower than normal in both the mother and one sibling MM. Skin biopsies were taken from JM, AM, the mother and sibling MM in order to determine the activity of OKT in extracts of cultured skin fibroblasts. Little enzyme activity could be demonstrated in JM and AM whilst there was a reduction in activity to 36.5%in the mother and 44% in MM of the mean activity found in our control preparations (Shih et al. 1978) .
Lysine monohydrochloride 0.3 g/kg/day was given with meals for ten weeks to JM and AM. As there was only a slight reduction in plasma ornithine their protein intake was lowered to Ig/kg/day. A more rapid but limited fall in plasma ornithine levels occurred. pyridoxine 50 mg three times a day was then added without any further effect upon the ornithine levels ( Figure 3 ).
Discussion
We were fortunate to demonstrate the biochemical abnormality in JM and AM before the changes of gyrate atrophy were apparent, so that unlike others reported with the disorder, deterioration in their eyes may be prevented or slowed. Lysine monohydrochloride reduces plasma or" nithine and corrects the apparent lysine deficiency in hyperornithinaemia (Giordano et al. 1978) . It shares a common transport mechanism with ornithine, arginine and cystine for reabsorption in the renal tubules which are thought to be saturated by the high ornithine. Additional dietary lysine should allow successful competition with ornithine for reabsorption. This was reflected by over twofold increase in ornithine excretion following lysine supplements (Figure 3) . However, the plasma ornithine levels showed only a slow decline indicating a large intracellular pool of ornithine. At the end of 10 weeks there was only a 20% reduction in plasma level and therefore the protein intake was lowered to limit dietary arginine and reduce ornithine formation ( Figure I ). This hastened the fall in plasma ornithine which after five weeks fell to 60% of pretreatment level. Continuation of treatment had no further effect even after the daily addition of large amounts of pyridoxine, coenzyme for OKT.
In untreated patients with HOGA, there is no obvious correlation between the level (10-to 20fold) of plasma ornithine and gyrate atrophy (Takki & Simell 1976) . If there is an association this may only be apparent at much lower levels (5to Io-fold). Therefore the patients' ornithine levels are being measured and the progression of the eye changes monitored under the treatment described.
JM and AM were initially diagnosed as probable cystinurias. It was only after closer examination of the chromatography patterns that the correct diagnosis was made. Plasma amino acid analysis is therefore indicated in all patients with suspected cystinuria. Reduced gastric emptying for two years, after selective vagotomy and Billroth I gastrectomy, is described in a patient where repeated investigation had failed to show a cause. Operation revealed a ball valve obstruction at the gastroduodenal anastomosis due to a hyperplastic polyp which on histology showed mild dysplastic changes.
Case report
A fit 34-year-old man underwent a selective vagotomy and Billroth I antrectomy for a duodenal ulcer three years previously. The ulcer had been causing pain for eight years. Preoperative peak acid output under pentagastrin stimulation (PAOpg) was 47.2 mmoljhour. He made a good postoperative recovery.
He remained well until one year later when he started to complain of intermittent epigastric discomfort several hours after food, bad breath and belching. In addition the patient suffered from severe episodic diarrhoea passing, on average, four loose stools on one day per week. A barium meal and follow through at that time showed a large amount of fluid in the stomach but no evidence of recurrent ulceration; the transit time between stomach and duodenum seemed to be slow and gastric emptying studies (cine isotope) confirmed delayed gastric emptying. Endoscopy revealed food debris in the stomach but again no mechanical hold up. His symptoms at that time were not severe enough for surgery.
Three years postoperatively his symptoms gradually became more severe, in particular he was complaining of epigastric fullness and nausea. On abdominal examination no abnormality was detected. Investigations showed a haemoglobin of 15.8gjdl, an ESR ofl mm/l h; urea and electrolytes and liver function tests were normal; FAOpg was 12.6 mmoljh. Barium meal showed gastric hold up. At operation he was found to have a 'ball valve' obstruction at the gastroduodenal anastomosis due to an easily palpable flap of hypertrophied gastric mucosa ( Figure I) . The region of the anastomosis was excised and a Billroth I revision anastomosis performed.
Macroscopically the polyp was 2.0 em in diameter and situated on the gastric edge of the gastroduodenal anastomosis prolapsing through the stoma into the lumen of the duodenum.
